Dexorder

Blockstreet is a multichain platform driving USD1 stablecoin adoption, smart contract deployment, and cross-chain DeFi growth tools.

Mavryk Network is a Defi ecosystem that offers instant lending, liquidity mining, yield farming, and other DeFi opportunities.

Fidecoop is a non-profit corporation that offers financing, technical assistance, business support, and promotion.

Habitat for Humanity of Puerto Rico helps individuals and families achieve stability, self-reliance, and a better future through affordable housing.

Aspire Biopharma is a biotechnology company specializing in nanotechnology-based drug formulation and the development of medicinal products. The company focuses on enhancing drug delivery systems to improve bioavailability and therapeutic effectiveness. Its research and development efforts aim to advance pharmaceutical solutions across various therapeutic areas.

SOLX is a manufacturing company that develops and retails solar panels.

Red Cat is creating a complete drone supply chain that includes secure blockchain-based storage, analytics, and software as a service solutions for use in the drone sector.

Hospitri is a platform for Vacation Rental Management as a Service (VRMaaS) that aims to assist property managers and owners in automating, optimizing, and expanding their businesses.

Punybz facilitates corporate digital transformation with solutions that blend creativity, technology, and agility.

We are expanding the capabilities of marine aquaculture to deep-water fish, at scale, sustainably, and with premium quality

Island (ASX: ILA) is a drug repurposing company, focused on the rapid development of antiviral therapeutics for infectious diseases. We have a lead asset – ISLA-101 - that was initially developed by our wholly-owned subsidiary, Isla Pharmaceuticals. ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and other mosquitoes (or vector) borne diseases. Dengue fever is the very definition of an unmet medical need. While 390 million humans are infected each year, it is thought that around 30-50% of people with the disease do not present with symptoms, enabling the virus to spread within communities. Warming global climates are accelerating the presence of mosquito-borne viruses that can cause death to the US, Europe and Australia There is no specific pharmaceutical treatment and the one vaccine which exists is available to a highly restricted audience. Island has repurposed ISLA-101, an antiviral oral drug to treat mosquito-borne viruses (eg dengue fever / Zika) and intends to complete Phase II studies with a significantly de-risked clinical program.

Raincoat creates efficient embedded insurance products for climate events and the automated systems that support them. They collaborate with insurance companies, government entities, and financial organizations to expand into new markets and promote widespread climate resilience.